Researchers Create New Tool for Assessing Risk of Kidney Injury After Chemotherapy
March 28, 2024
March 28, 2024
BOSTON, Massachusetts, March 28 -- Brigham and Women's Hospital issued the following news release:
Using patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for moderate-to-severe kidney injury after receiving the chemotherapy drug cisplatin in the largest, first generalizable study of its kind
Cisplatin is a highly effective chemotherapy that has been used to treat cancer for decades, but it can cause . . .
Using patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for moderate-to-severe kidney injury after receiving the chemotherapy drug cisplatin in the largest, first generalizable study of its kind
Cisplatin is a highly effective chemotherapy that has been used to treat cancer for decades, but it can cause . . .